Specificity and tunability of efflux pumps: A new role for the proton gradient?

Matthew Gerry, Duncan Kirby, Boian S. Alexandrov, Dvira Segal, Anton Zilman

Abstract

Bacterial efflux pumps are essential components of multidrug resistance, capable of expelling a wide variety of antibiotics. While specificity is traditionally attributed to static binding affinities, this study proposes that the thermodynamic forces driving these pumps—the proton motive force (PMF)—actively tune their selectivity. Using Markov jump process models, we demonstrate that periplasmic pH and membrane potential independently shift the "sweet spot" of optimal drug binding affinity. This suggests that bacteria can dynamically adjust their resistance profiles by modulating their internal and external environments, offering a new perspective on non-equilibrium biological machines.

The Efflux Pump Paradox

Multidrug resistance remains a primary challenge in global health, with bacterial efflux pumps serving as a first line of defense. These molecular machines, such as the AcrAB-TolC system in E. coli, reside in the bacterial membrane and physically transport antibiotics out of the cell.

Schematic of a bacterial efflux pump transporting drugs and protons across the membrane.

The central paradox of these pumps is their "broad specificity": they recognize an immense variety of drug molecules while avoiding the accidental expulsion of essential nutrients. Traditionally, this selectivity was thought to be determined solely by the equilibrium binding affinity ($K_D$) of the pump's binding pocket. However, this paper investigates whether the proton gradient and electric potential—collectively the proton motive force (PMF)—play a more active role in defining transport specificity.

Kinetic Modeling of Pump Operation

To explore this, the authors developed two mathematical models based on Markov jump processes, treating the pump as a discrete cyclic stochastic machine.

The three-state kinetic model (A) and its corresponding Markov jump process (B) used to describe pump transitions.
  1. Three-state kinetic model: A minimal unicyclic model tracking transitions between empty, drug-bound, and proton-bound states.
  2. Five-state kinetic model: A more detailed representation that separates conformational changes, drug release, and proton release into distinct steps.

These models utilize local detailed balance relations to ensure thermodynamic consistency while operating far from equilibrium. By parameterizing these models with data from the AcrAB-TolC and MexAB-OprM systems, the researchers calculated steady-state drug throughput under varying environmental conditions.

Key Insights: The PMF as a Tuner

The study reveals that the PMF is not merely a source of "fuel" but a sophisticated "tuner" for pump performance.

Specificity as a Non-Equilibrium Property

In equilibrium systems, binding affinity is the sole determinant of selectivity. However, because efflux pumps operate far from equilibrium, the "effective" affinity ($K_M$) becomes a dynamic variable influenced by the rate of proton flux. The coupling to the proton gradient allows these pumps to achieve higher specificity than passive channels by effectively "filtering" molecules based on their kinetic properties.

pH-Dependent "Sweet Spot" Shifts

The researchers identified an optimal binding affinity where efflux is maximized. If a drug binds too weakly, it detaches before transport; if it binds too strongly, the pump cannot release it. Crucially, changing the periplasmic pH shifts this "sweet spot." A lower pH (higher proton concentration) accelerates the pumping cycle, allowing the pump to efficiently handle drugs with lower binding affinities. In both the 3-state and 5-state models, the optimal $K_D$ shifted by a factor of approximately five as pH moved from 7 to 5.

Conclusion and Future Directions

This research highlights a fundamental trade-off between the speed of drug extrusion and the energy dissipation required to maintain the PMF. While the current models assume a strict unicyclic stoichiometry, they provide a robust framework for understanding how environmental factors influence antibiotic resistance.

The next critical step is experimental validation. By precisely manipulating periplasmic pH and membrane potential in vivo, researchers can test these predicted shifts in efflux rates. Understanding these tuning mechanisms could lead to the development of adjuvants that disrupt a pump's ability to adapt its specificity, restoring the efficacy of existing antibiotics.

Summary updated

Abstract

Bacterial efflux pumps that transport antibacterial drugs out of the bacterial cells have broad specificity, commonly leading to broad spectrum resistance and limiting treatment strategies for infections. It remains unclear how efflux pumps can maintain this broad spectrum specificity to diverse drug molecules while limiting the efflux of other cytoplasmic content. We investigate the origins of this broad specificity using theoretical models informed by the experimentally determined structural and kinetic properties of efflux pumps. We develop a set of mathematical models describing operation of efflux pumps as a discrete cyclic stochastic process across a network of states characterizing pump conformations and the presence/absence of bound ligands and protons. We find that the pump specificity is determined not solely by the drug affinity to the pump–as is commonly assumed–but it is also directly affected by the periplasmic pH and the transmembrane potential. Therefore, the pump effectiveness in removing a particular drug molecule from the cell can be tuned by modifying the proton concentration gradient and the voltage drop across the membrane. Furthermore, we find that while both the proton concentration gradient across the membrane and the transmembrane potential contribute to the thermodynamic force driving the pump, their effects on the efflux enter not strictly in a combined proton motive force, but rather they have two distinguishable effects on the overall throughput. These results potentially explain the broad specificity of efflux pumps and suggest ways to overcome bacterial resistance, while highlighting unexpected effects of thermodynamic driving forces out of equilibrium.
BibTeX
@article{gerry2025specificity,
  author = {Matthew Gerry and Duncan Kirby and Boian S. Alexandrov and Dvira Segal and Anton Zilman},
  title = {{Specificity and tunability of efflux pumps: A new role for the proton gradient?}},
  journal = {PLOS Computational Biology},
  year = {2025},
  doi = {10.1371/journal.pcbi.1012772},
}
Figure